An underground economy for unlicensed slimming medications is propelled by TikTok fitness influencers and sellers on messaging platforms, according to new investigations.
Investigational Treatment Acquiring Traction Via Social Media
Retatrutide, which remains in clinical trials, is being advertised by social media influencers for its alleged weight-reducing effects. Viewers are encouraged to contact these accounts directly for source information, while also receiving promotional offers.
Thriving Commerce on Messaging Platforms
Additionally, a robust trade exists on Telegram, where groups with thousands of members share comparison photos, administration instructions and assertions of next-day UK delivery. Sellers market the drug there before redirecting buyers to other platforms for purchases.
Understanding Retatrutide
This medication is an investigational injectable developed by American pharmaceutical company Eli Lilly. The treatment targets three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could assist patients lose up to 25% of their body weight. Nicknamed the “triple G”, the drug is being promoted online as the next Ozempic.
Medical Professionals Express Worries
Nevertheless, doctors and chemists have warned that the distribution of what is still an unapproved medication in the United Kingdom is worrisome and could result in individuals administering products of unknown origin.
Some professionals said the demand for the experimental drug could be connected to the increasing cost of licensed weight loss products such as Mounjaro.
Legal Position and Enforcement
Marketing retatrutide on TikTok or Telegram is prohibited in the UK, as it is an unlicensed drug that must not be promoted or distributed for human use under the British medical regulations.
Some content creators try to sidestep the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled substance, but advertising and supply can still violate pharmaceutical, advertising, and customer laws, potentially leading to fines, prosecution or prison.
Platform Response and Material Removal
Based on TikTok, the service has removed problematic content and prohibited associated hashtags and query recommendations. The company stated it was committed to keeping the platform safe and investing in strengthening compliance measures.
Digital Trading Operations
Research also discovered communities with up to nine thousand members selling retatrutide using the platform's built-in search feature, which operates like a online catalog. Typing “retatrutide” immediately brings up groups with numerous of members, populated with photos of slimming results, positive testimonials and detailed instructions for mixing or injecting at home.
After moments of entering one group, a vendor posted WhatsApp details, where the majority of purchases occur. The vendor sent an guidebook and promised delivery within 48 hours. When asked whether the product was authentic, one seller responded: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. Not one inquired about body mass, medical conditions or past usage.
Item Details and Pricing
Within these communities, messages show black plastic parcels with Royal Mail labels, claiming to contain fresh supplies. One communication read: “It took eight of us to load them this morning.”
Customers can choose between powder vials, prepared at home with sterile water, or ready-to-use injectors typically priced at 160 pounds for 20 milligrams. When asked how long a injector should be used, vendors give conflicting answers ranging from a several days to “depends on your body”.
Service Moderation and Safety Measures
A spokesperson for Telegram said it actively monitored dangerous content on its service including material that promoted the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.
Healthcare Professional Cautions
“People are administering materials they can’t verify. Even if the research behind retatrutide is valid, these digital products may not contain what they advertise,” said Jason Murphy, the head of pharmaceutical services at Chemist4U.
Dr Crystal Wyllie of Asda Online Doctor connected the surge in demand to recent price rises for approved weight-loss drugs such as Mounjaro. “With costs increasing, patients are turning to social media. But counterfeit treatments are highly risky. You cannot know what’s inside or whether the environment they were produced in was sterile,” she explained.
Her team has previously encountered individuals injured by self-injection from unconfirmed sources. “We understand the frustration, but buying from Telegram or WhatsApp is gambling with your well-being,” said Wyllie. “These substances could be impure or improperly measured.”
Manufacturer Position
A spokesperson from the pharmaceutical company stated retatrutide was in third stage clinical trials and had not been evaluated or authorized by any regulatory agency globally. “Therefore at this point no one can market [it] for personal consumption,” they explained, noting that any product “falsely representing itself as a Lilly experimental product not yet authorized … may expose patients to potentially serious health risks”.
